James Shaw


James is a partner in the corporate team and a leading transactional venture capital lawyer, advising entrepreneurs, companies and investors through the funding life-cycle.

He was the co-founder of tech law firm JAG Shaw Baker which merged with Withers to create a new legal offering, Withers tech, in 2018.

James has two decades of experience helping entrepreneurs, high-growth technology based companies and investors navigate their way through multiple rounds of financing, growth, scale-up and exit/liquidity events. He’s ranked as a recommended lawyer for Venture Capital in the 2017 edition of the Legal 500.

James is considered to be one of the leading University spin-out lawyers for life sciences companies and he actively advises on spin-out activity from several of the leading Universities in the UK and Scotland including Oxford and Cambridge University. James works as a mentor and speaker with the Oxford Foundry, part of Oxford University’s incubator initiative for past and present students.

As a close adviser to many companies and investors, James is also acting General Counsel to Bioven, Mologic Limited and Grampian BioPartners.

James is a graduate of both St Andrews University (BSc Hons) and Edinburgh University (LLB), and, as a Scottish qualified lawyer, holds a committee position on the Society of Scottish Lawyers in London and is a Writer to Her Majesty’s Signet.

Focus areas





Bioven – an immuno-oncology business with a lead product in phase III trials and a pipeline of pre-clinical assets.

Mologic Limited – a point-of-care diagnostics spin-out from Alere.

Grampian BioPartners – a specialist life science business angel syndicate, able to act as a micro-lead on specialist life-science deals.

Writer to Her Majesty’s Signet

A Q & A with James Shaw, Biotech and Money, Drugs & Dealers, May 2016

What You Need To Know About Intellectual Property And Brexit, Financier Worldwide, January 2017

Society of Scottish Lawyers in London, committee member

Early Stage Funding, Startup and SME club, 3/8/2018

Funding AI, VR And AR Startups In MedTech For Growth, February 2018 (panel member)

What Does The Future Hold For Digital Health? Biotechs and the City, September 2017 (panel member)


I'm passionate about helping entrepreneurs and investors create a new era in healthcare

We’ve all seen the headlines and heard the lawyer jokes. Surveys say that half of all lawyers wouldn’t enter the profession if they had it to do over or even recommend being a lawyer to their children, so why did I become a lawyer? The reason is simple; I can make a difference. Whether it’s helping life sciences and biotech spinouts become companies that can develop novel therapies or working with startups to help them bring new technologies like virtual reality, augmented reality and artificial intelligence, to market, I get to help these entrepreneurs and investors, create a new era in healthcare.

From genetic research and emergency room management to clinical trials, virtual nurses and drug discovery, these new technologies are already changing how we interact with healthcare globally; and as a lawyer in this sector, I get to be a part and work alongside an industry that has the potential to redesign how health care is done and how consumers access and use it.

Now, do you want to hear a lawyer joke?



  • English
  • French